LEXEO THERAPEUTICS, INC.

Press Releases Lexeo Therapeutics, Inc.

Equities

LXEO

US52886X1072

Market Closed - Nasdaq Other stock markets 04:00:00 2024-05-10 pm EDT			5-day change	1st Jan Change
13.14 ^USD	-9.38%		+2.90%	-2.09%

May. 09	Lexeo Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
May. 01	Certain Options of Lexeo Therapeutics, Inc. are subject to a Lock-Up Agreement Ending on 1-MAY-2024.	CI

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Lexeo Therapeutics Reports First Quarter 2024 Financial Results and Operational Highlights	May. 09	AQ
Lexeo Therapeutics to Participate in Upcoming Investor Conferences	May. 07	AQ
Lexeo Therapeutics Announces License Agreement to Accelerate Development of LX2006 for the Treatment of Friedreich Ataxia Cardiomyopathy	Apr. 22	AQ
LEXEO THERAPEUTICS GRANTED FDA FAST TRACK DESIGNATION FOR LX2006, AN AAV-BASED GENE THERAPY CANDIDATE FOR THE TREATMENT OF FRIEDREICH'S ATAXIA CARDIOMYOPATHY	Apr. 17	AQ
Lexeo Therapeutics Granted FDA Fast Track Designation for LX2006, an AAV-Based Gene Therapy Candidate for the Treatment of Friedreich’s Ataxia Cardiomyopathy	Apr. 16	AQ
Lexeo Therapeutics Announces Closing of Oversubscribed $95.0 Million Equity Financing	Mar. 13	AQ
Lexeo Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Operational Highlights	Mar. 11	AQ
Lexeo Therapeutics Announces Oversubscribed $95.0 Million Equity Financing	Mar. 11	AQ
Lexeo Therapeutics Strengthens Clinical Development Leadership with New Executive Appointments	Feb. 05	AQ
Lexeo Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference	Jan. 03	AQ
Lexeo Therapeutics Granted FDA Fast Track Designation and Orphan Drug Designation for LX2020, an AAV-Based Gene Therapy Candidate for PKP2 Arrhythmogenic Cardiomyopathy (ACM)	Dec. 18	AQ
Lexeo Therapeutics Reports Third Quarter 2023 Financial Results and Operational Highlights	Dec. 11	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.

SIGN UP NOW